151 related articles for article (PubMed ID: 16702519)
1. Molecular determinants in targeted therapy for esophageal adenocarcinoma.
Vallböhmer D; Peters JH; Kuramochi H; Oh D; Yang D; Shimizu D; DeMeester SR; Hagen JA; Chandrasoma PT; Danenberg KD; Danenberg PV; DeMeester TR
Arch Surg; 2006 May; 141(5):476-81; discussion 481-2. PubMed ID: 16702519
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
[TBL] [Abstract][Full Text] [Related]
3. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.
Vallböhmer D; Peters JH; Oh D; Kuramochi H; Shimizu D; Demeester SR; Hagen JA; Chandrasoma PT; Danenberg KD; DeMeester TR; Danenberg P
Surgery; 2005 Oct; 138(4):701-6; discussion 706-7. PubMed ID: 16269299
[TBL] [Abstract][Full Text] [Related]
4. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
5. Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus.
Vallböhmer D; DeMeester SR; Oh DS; Banki F; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; Chandrasoma PT; Peters JH; DeMeester TR
Am J Gastroenterol; 2006 Jul; 101(7):1458-66. PubMed ID: 16863546
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.
Toiyama Y; Inoue Y; Saigusa S; Okugawa Y; Yokoe T; Tanaka K; Miki C; Kusunoki M
Clin Oncol (R Coll Radiol); 2010 May; 22(4):272-80. PubMed ID: 20117921
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.
Schneider S; Uchida K; Brabender J; Baldus SE; Yochim J; Danenberg KD; Salonga D; Chen P; Tsao-Wei D; Groshen S; Hoelscher AH; Schneider PM; Danenberg PV
J Am Coll Surg; 2005 Mar; 200(3):336-44. PubMed ID: 15737843
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma.
von Rahden BH; Stein HJ; Pühringer F; Koch I; Langer R; Piontek G; Siewert JR; Höfler H; Sarbia M
Cancer Res; 2005 Jun; 65(12):5038-44. PubMed ID: 15958546
[TBL] [Abstract][Full Text] [Related]
9. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
Xi H; Baldus SE; Warnecke-Eberz U; Brabender J; Neiss S; Metzger R; Ling FC; Dienes HP; Bollschweiler E; Moenig S; Mueller RP; Hoelscher AH; Schneider PM
Clin Cancer Res; 2005 Dec; 11(23):8341-7. PubMed ID: 16322294
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
Miura N; Nakamura H; Sato R; Tsukamoto T; Harada T; Takahashi S; Adachi Y; Shomori K; Sano A; Kishimoto Y; Ito H; Hasegawa J; Shiota G
Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
[TBL] [Abstract][Full Text] [Related]
13. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
Yu ZT; Zhao HF; Shang XB
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
[TBL] [Abstract][Full Text] [Related]
14. Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery.
Oh DS; DeMeester SR; Vallbohmer D; Mori R; Kuramochi H; Hagen JA; Lipham J; Danenberg KD; Danenberg PV; Chandrasoma P; DeMeester TR
Arch Surg; 2007 Jun; 142(6):554-9; discussion 559-60. PubMed ID: 17576892
[TBL] [Abstract][Full Text] [Related]
15. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
Abraham SC; Wang H; Wang KK; Wu TT
Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of coexpression of cyclooxygenases-2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma.
Pan J; Kong L; Lin S; Chen G; Chen Q; Lu JJ
Laryngoscope; 2008 Nov; 118(11):1970-5. PubMed ID: 18758376
[TBL] [Abstract][Full Text] [Related]
17. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma.
Gockel I; Schimanski CC; Heinrich C; Wehler T; Frerichs K; Drescher D; von Langsdorff C; Domeyer M; Biesterfeld S; Galle PR; Junginger T; Moehler M
BMC Cancer; 2006 Dec; 6():290. PubMed ID: 17176471
[TBL] [Abstract][Full Text] [Related]
18. Genetic variations in angiogenesis pathway genes predict tumor recurrence in localized adenocarcinoma of the esophagus.
Lurje G; Leers JM; Pohl A; Oezcelik A; Zhang W; Ayazi S; Winder T; Ning Y; Yang D; Klipfel NE; Chandrasoma P; Hagen JA; DeMeester SR; DeMeester TR; Lenz HJ
Ann Surg; 2010 May; 251(5):857-64. PubMed ID: 20101173
[TBL] [Abstract][Full Text] [Related]
19. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.
Jia RP; Xu LW; Su Q; Zhao JH; Li WC; Wang F; Xu Z
Asian J Androl; 2008 Sep; 10(5):758-64. PubMed ID: 18645679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
